Diagnostic arthrocentesis for suspicion of gout is safe and well tolerated

• Main Authors: Taylor W., Fransen J., Dalbeth N., Neogi T., Schumacher H., Brown M., Louthrenoo W., Vazquez-Mellado J., Eliseev M., McCarthy G., Stamp L., Perez-Ruiz F., Sivera F., Ea H., Gerritsen M., Scire C., Cavagna L., Lin C., Chou Y., Tausche A., Da Rocha Castelar-Pinheiro G., Janssen M., Chen J., Slot O., Cimmino M., Uhlig T., Jansen T.
• Format: Journal
• Published: 2017
• Online Access: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85011867486&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/42671
• Institution: Chiang Mai University

The Journal of Rheumatology Copyright © 2016. All rights reserved. Objective. To determine the frequency of adverse events of diagnostic arthrocentesis in patients with possible gout. Methods. Consecutive patients underwent arthrocentesis and were evaluated at 6 weeks to determine adverse events. The 95% CI were obtained by bootstrapping. Results. Arthrocentesis was performed in 910 patients, and 887 (97.5%) were evaluated for adverse events. Any adverse event was observed in 12 participants (1.4%, 95% CI 0.6-2.1). There was 1 case (0.1%, 95% CI 0-0.34) of septic arthritis. Conclusions. Diagnostic arthrocentesis is associated with a low frequency of adverse events. Septic arthritis rarely occurs.